What the research found

A longitudinal study tracking disease outcomes over roughly a decade found that individuals combining both aerobic fitness and grip strength experienced substantially lower rates of developing multiple concurrent chronic diseases, compared to those ranking low on both measures. The protective effect was additive—having strength and endurance capacity appeared more beneficial than excelling in either domain alone.

In a randomised trial with older adults, a structured movement protocol emphasising directional changes and intentional gait patterns—layered on top of conventional group exercise—yielded measurable gains in walking speed, leg muscle mass, grip strength, and self-reported functional independence relative to exercise without this movement-specific component.

A synthesis of mechanistic research suggests that caloric restriction, intermittent fasting, and certain pharmacological compounds (metformin, resveratrol) converge on shared cellular pathways involved in ageing, with documented effects on insulin sensitivity and inflammatory markers. However, evidence for sustained benefit in non-diseased populations remains limited.

Why it matters for you

If you're tracking strength and VO₂ metrics via testing or wearables, the first finding argues against treating these as independent priorities. Someone optimising for longevity should ensure both aerobic capacity (via sustained zone 2 work, intervals, or sport) and muscular strength have genuine training time. Your grip strength data, if you're measuring it, is a practical proxy—easy to track longitudinally and correlated with systemic resilience.

The gait work is less glamorous than a heavy squat or a 5K PR, but it directly transfers to what matters later: avoiding falls, maintaining independence in daily tasks, and preserving leg mass. If you're training but not regularly rehearsing multi-directional movement or balance under fatigue, this is a cheap addition to your protocol.

On the nutrition side, the review acknowledges what MyKine users already know—metformin, resveratrol, and fasting protocols are popular interventions in the biohacking space. The honest takeaway is that while these show mechanistic promise, long-term human data in healthy people is sparse. It's reasonable to experiment with fasting protocols or track inflammatory biomarkers (hsCRP, IL-6) before and after a dietary change, but the evidence still favours consistent adherence to a sensible diet over pill-based shortcuts.

Caveats

  • The multimorbidity study is observational; causality isn't established (fitness may correlate with overall health behaviours).
  • The gait trial involved older adults; effects in younger populations may differ.
  • CR-mimetics show mechanistic promise in cells and animal models; translation to durable human benefit is unproven.
  • Long-term safety and efficacy of intermittent fasting or metformin in healthy individuals remain understudied.